Skip to main content
KARD
NASDAQ Life Sciences

Kardigan Posts 64-Cent Quarterly Loss as Cash Burn Draws Focus

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Healthcare
Sentiment info
Negative
Importance info
7
Price
$15.68
Mkt Cap
$1.466B
52W Low
$12.23
52W High
$27
52W Position info
28% above low
Off High info
42% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

KARD sits 28% above its 52-week low of $12.23.

Summary

Kardigan reported a third-quarter loss of 64 cents a share, with the quarterly loss totaling $58.6 million. It was the company's first quarterly print since the Q2 net loss of $116.2 million that included a $43.5 million non-cash charge from milestone liability revaluation. The company ended Q2 with $660.7 million in cash and investments, so the size of this quarter's burn is the number that matters for how long the pipeline stays funded. The loss lands days after Kardigan finished enrolling 156 patients in the Phase 2b KATALYST-AV trial of ataciguat in aortic stenosis, an event that came with an amended 8-K on November 6. With the trial now fully enrolled, spending shifts from enrollment to running the study, and the market will judge whether the loss reflects that step-up. No revenue or cash balance figures accompanied the headline, so the full 10-Q will carry the detail that determines whether this is a routine development-stage loss or a faster burn than expected.

At the time of this announcement, KARD was trading at $15.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.5B. The 52-week trading range was $12.23 to $27.00. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

KARD - Latest Insights

KARD
Nov 06, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.93
Real-time Price: $14.12 info
Change: -$1.81 (-11%) info
Market Cap: $1.32B info
KARD
Nov 06, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $15.52
Real-time Price: $14.12 info
Change: -$1.40 (-9%) info
Market Cap: $1.32B info
KARD
Aug 11, 2026, 7:10 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $14.12 info
Change: -$6.29 (-31%) info
Market Cap: $1.32B info
KARD
Aug 11, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $14.12 info
Change: -$6.29 (-31%) info
Market Cap: $1.32B info
KARD
Aug 11, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.41
Real-time Price: $14.12 info
Change: -$6.29 (-31%) info
Market Cap: $1.32B info